Association of the CCR5delta32 mutation with improved response to antiretroviral therapy

JAMA. 1999 Aug 25;282(8):734. doi: 10.1001/jama.282.8.734.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Disease Progression
  • Genotype
  • HIV Infections / drug therapy*
  • HIV Infections / genetics*
  • HIV Infections / immunology
  • HIV Protease Inhibitors / therapeutic use*
  • HIV-1
  • Humans
  • Mutation
  • Receptors, CCR5 / genetics*
  • Treatment Outcome
  • Viral Load

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Receptors, CCR5